Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-23-039901

CEO acquired 7,979 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Shah Gaurav CEO 2023-08-14 Option exercise +7,979 529,621 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Shah Gaurav CEO 2023-08-14 Option exercise · Restricted Stock Units −7,979 47,877 D: show line 2 in the form
Loading xslF345X05/form4.xml…